Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer

详细信息    查看全文

• 作者：Teng Hou¹ ; Dongxia Liang¹ ; Liqun Xu ; Xin Huang ; Yongwen Huang ; Yanna Zhang ; ^{zhangyannapds@gmail.com}
• 关键词：Atypical chemokine receptors ; DARC ; D6 ; CCX-CKR ; Cervical squamous cell carcinoma ; Prognosis
• 刊名：Gynecologic Oncology
• 出版年：2013
• 出版时间：July, 2013
• 年：2013
• 卷：130
• 期：1
• 页码：181-187
• 全文大小：1421 K

文摘

Objective

Atypical chemokine receptors (ACRs), including CCX-CKR, DARC, and D6, have been reported to be involved in cancer invasion and metastasis. The objective of this study was to investigate the prognostic importance of ACRs in patients with cervical squamous cell carcinoma (CSCC).

Methods

The expression of three ACRs was investigated by immunohistochemical (IHC) examination in a total of 317 cervical specimens including 40 normal cervical tissues, 50 cases of carcinoma in situ of cervix (CIS), and 227 cases of CSCC by immunohistochemistry.

Results

The expression rate of DARC and CCX-CKR in CSCC, CIS, and normal cervix increased gradually (p < 0.01). D6 expression is decreased in CSCC compared to either in CIS or in normal cervix (p < 0.05). In addition, the expression of CCL2 and CCL19 was inversely associated with ACR expression (p < 0.05), while that of LCA was positively correlated with ACR expression (p < 0.05). Moreover, DARC expression, CCX-CKR expression, and ACR coexpression were negatively correlated with lymph node metastasis (P < 0.01). D6 expression and ACR coexpression were negatively related to tumor size (p = 0.018) and recurrence (p = 0.028). In multivariate Cox regression analysis, CCX-CKR expression was a positive indicator for overall survival (p = 0.008), and D6 expression was an independent predictor of both overall and recurrence-free survival (p = 0.041) in CSCC.

Conclusions

Our results suggest that the loss of ACRs may play important roles in the tumorigenesis and migration of cervical cancer. ACR expression may be considered as prognostic markers in patients with CSCC.